2. EDUCATION AND TRAINING
March’ 2008-May’2009
Research Scientist
Connexios Life Sciences, Bangalore, INDIA | www.connexios.com
▪ Assay development & Standardization for efficacy (Biosimilars/Bioequivalence studies)
▪ Toxicity studies (Toxicogenomics,ADME/Tox), its standardization/optimization.
▪ High-throughput screening (HTS) of NCE’s(Natural/Synthetic therapeutic molecules) using mammalian cell lines(C2C12,H9C2,3T3-L1,HepG2,HEK293,CHO-K1).
▪ Projects handled:
Investigated the effect of Hepatocyte Nuclear Factor-4# phosphorylation and its transactivation and assessing AMPK activation in Hepatocytes on Type 2 Diabetes assay model.
Assessed the effect of cationic amphiphilic drugs induced Phospholipidosis and their in-vitro high throughput screening(HTS) in CHO-K1 cell line using the fluorescent-labeled phospholipid probe.
Standardized the bio-assay for the analysis of Nephrotoxicity (ADME/Tox) in HEK-293 cell lines and in-vitro screening of the NCE’S(New Chemical Entities) on induced Type 2 Diabetic assay model.
Investigated the relationship between IMTG (Intramuscular triglycerides) and Insulin resistance in Obese Type 2 Diabetic in-vitro model on C2C12 cell line followed by high throughput screening of new chemical entities for its respective efficacy.
Investigated the effect of HSD11b1 mediated Endoplasmic Reticulum stress (ADME/Tox) on Type 2 Diabetic invitro model using C2C12 cell line.
Studied the expression of CPT1A gene and ECHS1 gene which play a major role in accumulation of fat in the liver and is associated with insulin resistance and type 2 diabetes mellitus followed by high throughput in-vitro screening of new chemical entity for its efficacy.
Research & Development | Drug discovery program
August 2010- October 2014
Research Intern
Nicholas Piramal Research Centre, Mumbai, INDIA | www.piramal.com
▪ Completed project work entitled “Bioactivity guided fractionation and in-vitro screening of MHCO2 isolated from marine bacteria showing Anti-Diabetic Activity”.
▪ Assay development & Standardization for efficacy (Bio-similar / Bioequivalence studies) and high- throughput screening (HTS) of NCE’s(Natural/Synthetic therapeutic molecules) using mammalian cell lines(L6),Radio-isotope handling.
Research & Development | Drug discovery program
August 2006-December 2007
Master of Technology (M.Tech) in Biotechnology
Bundelkhand University, INDIA
Medical Biotechnology, Animal Cell Culture, Bio-analytical techniques in Biochemistry, Fermentation Technology, Immunology, Molecular Biology and Biochemistry
July 2002 - July 2006
Bachelor of Technology (B.Tech) in Biotechnology
Bundelkhand University, INDIA
Animal Biotechnology, Bioprocess Technology, Fermentation Technology, Immunology, Molecular Biology and Biochemistry, Biostatics.